Recent studies have demonstrated that miR-30d prevents pathological cardiac hypertrophy via negatively regulating its target genes MAP4K4 and GRP78 and inhibiting the prohypertrophic nuclear factor of activated T cells[10]. This evidence concerns the gene HSPA5 and cardiac hypertrophy.